Phase II clinical trial of high-dose recombinant human tumor necrosis factor

H. Lenk; St. Tanneberger; U. M�ller; J. Ebert; T. Shiga

doi:10.1007/bf00257449

Phase II clinical trial of high-dose recombinant human tumor necrosis factor

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00257449 ◽

1989 ◽

Vol 24 (6) ◽

Cited By ~ 39

Author(s):

H. Lenk ◽

St. Tanneberger ◽

U. M�ller ◽

J. Ebert ◽

T. Shiga

Keyword(s):

Clinical Trial ◽

Tumor Necrosis Factor ◽

Phase Ii ◽

Tumor Necrosis ◽

Human Tumor ◽

Phase Ii Clinical Trial ◽

High Dose ◽

Human Tumor Necrosis Factor ◽

Necrosis Factor

Download Full-text

Phase II clinical trial of human tumor necrosis factor Sertenef (PT-050) produced by recombinant DNA technology to skin malignant cancers.

Skin Cancer ◽

10.5227/skincancer.5.210 ◽

1990 ◽

Vol 5 (1) ◽

pp. 210-226 ◽

Cited By ~ 1

Author(s):

Shigeo IKEDA ◽

Kazuyuki ISHIHARA

Keyword(s):

Clinical Trial ◽

Tumor Necrosis Factor ◽

Phase Ii ◽

Tumor Necrosis ◽

Recombinant Dna ◽

Human Tumor ◽

Human Tumor Necrosis Factor ◽

Recombinant Dna Technology ◽

Dna Technology ◽

Necrosis Factor

Download Full-text

A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00267953 ◽

1989 ◽

Vol 23 (3) ◽

Cited By ~ 25

Author(s):

PatrickJ. Creaven ◽

DeanE. Brenner ◽

J.Wayne Cowens ◽

RobertP. Huben ◽

RichardM. Wolf ◽

...

Keyword(s):

Clinical Trial ◽

Tumor Necrosis Factor ◽

Phase I ◽

Tumor Necrosis ◽

Human Tumor ◽

Phase I Clinical Trial ◽

Human Tumor Necrosis Factor ◽

Necrosis Factor

Download Full-text

A Phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer

Klinische Wochenschrift ◽

10.1007/bf01666852 ◽

1991 ◽

Vol 69 (6) ◽

pp. 261-268 ◽

Cited By ~ 14

Author(s):

W. Fiedler ◽

W. Zeller ◽

C. -J. Peimann ◽

H. -J. Weh ◽

D. K. Hossfeld

Keyword(s):

Colorectal Cancer ◽

Tumor Necrosis Factor ◽

Phase Ii ◽

Tumor Necrosis ◽

Human Tumor ◽

Gamma Interferon ◽

Human Tumor Necrosis Factor ◽

Necrosis Factor

Download Full-text

Phase I clinical trial of recombinant human tumor necrosis factor

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00253968 ◽

1987 ◽

Vol 20 (2) ◽

Cited By ~ 40

Author(s):

PatrickJ. Creaven ◽

JohnE. Plager ◽

Sherry Dupere ◽

RobertP. Huben ◽

Hiroshi Takita ◽

...

Keyword(s):

Clinical Trial ◽

Tumor Necrosis Factor ◽

Phase I ◽

Tumor Necrosis ◽

Human Tumor ◽

Phase I Clinical Trial ◽

Human Tumor Necrosis Factor ◽

Necrosis Factor

Download Full-text

A phase I clinical trial of recombinant human tumor necrosis factor

Cancer ◽

10.1002/1097-0142(19881215)62:12<2467::aid-cncr2820621202>3.0.co;2-5 ◽

1988 ◽

Vol 62 (12) ◽

pp. 2467-2471 ◽

Cited By ~ 84

Author(s):

Edward T. Creagan ◽

John S. Kovach ◽

Charles G. Moertel ◽

Stephen Frytak ◽

Larry K. Kvols

Keyword(s):

Clinical Trial ◽

Tumor Necrosis Factor ◽

Phase I ◽

Tumor Necrosis ◽

Human Tumor ◽

Phase I Clinical Trial ◽

Human Tumor Necrosis Factor ◽

Necrosis Factor

Download Full-text

The Effect of Recombinant Human Tumor Necrosis Factor-a on Ehrlich Ascites Tumor Growth

Journal of Environmental Pathology Toxicology and Oncology ◽

10.1615/jenvironpatholtoxicoloncol.v21.i1.90 ◽

2002 ◽

Vol 21 (1) ◽

pp. 6

Author(s):

Slawomir Terlikowski ◽

Mariola Sulkowska ◽

Henryk F. Nowak

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Growth ◽

Tumor Necrosis ◽

Human Tumor ◽

Ehrlich Ascites Tumor ◽

Ascites Tumor ◽

Human Tumor Necrosis Factor ◽

Ehrlich Ascites ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1103232.565151 ◽

2008 ◽

Author(s):

Thomas Pap ◽

Marvin Peters ◽

Berno Dankbar

Keyword(s):

Tumor Necrosis Factor ◽

Transgenic Mice ◽

Tumor Necrosis ◽

Human Tumor ◽

Bone Destruction ◽

Cathepsin K ◽

Human Tumor Necrosis Factor ◽

K Deficiency ◽

Necrosis Factor

Download Full-text

A case of toxic epidermal necrolysis successfully treated with recombinant human tumor necrosis factor-α receptor II:IgG Fc fusion protein combined with glucocorticoids

Chinese Journal of Dermatology ◽

10.35541/cjd.20190896 ◽

2020 ◽

Keyword(s):

Tumor Necrosis Factor ◽

Fusion Protein ◽

Toxic Epidermal Necrolysis ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Human Tumor ◽

Human Tumor Necrosis Factor ◽

Fc Fusion Protein ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Association between polymorphisms in human tumor necrosis factor-alpha (−308) and -beta (252) genes and development of gestational diabetes mellitus

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2010.01.028 ◽

2010 ◽

Vol 88 (2) ◽

pp. 139-145 ◽

Cited By ~ 12

Author(s):

Shabnam Montazeri ◽

Sivalingam Nalliah ◽

Ammu Kutty Radhakrishnan

Keyword(s):

Diabetes Mellitus ◽

Tumor Necrosis Factor ◽

Gestational Diabetes ◽

Gestational Diabetes Mellitus ◽

Tumor Necrosis ◽

Human Tumor ◽

Human Tumor Necrosis Factor ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.

Journal of Biological Chemistry ◽

10.1016/s0021-9258(19)74322-1 ◽

1993 ◽

Vol 268 (35) ◽

pp. 26350-26357

Author(s):

H Loetscher ◽

D Stueber ◽

D Banner ◽

F Mackay ◽

W Lesslauer

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Human Tumor ◽

Tnf Alpha ◽

Tnf Receptors ◽

Human Tumor Necrosis Factor ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text